Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,464,000 | 9,123,000 | 13,979,000 | 14,546,000 | 12,346,000 |
| Marketable Securities | 816,000 | 130,000 | 2,987,000 | 1,285,000 | 3,047,000 |
| Receivables | 10,921,000 | 9,886,000 | 9,369,000 | 8,501,000 | 7,685,000 |
| Inventories | 2,662,000 | 2,339,000 | 2,095,000 | 2,074,000 | 4,293,000 |
| Other current assets | 5,907,000 | 5,795,000 | 4,832,000 | 3,786,000 | 1,983,000 |
| TOTAL | $31,770,000 | $27,273,000 | $33,262,000 | $30,192,000 | $29,354,000 |
| Non-Current Assets | |||||
| PPE Net | 6,646,000 | 6,255,000 | 6,049,000 | 5,886,000 | 6,252,000 |
| Investments And Advances | 364,000 | 0 | 0 | 433,000 | 767,000 |
| Intangibles | 48,241,000 | 57,008,000 | 63,029,000 | 73,790,000 | 86,457,000 |
| Other Non-Current Assets | 8,138,000 | 6,284,000 | 6,974,000 | 8,180,000 | 7,114,000 |
| TOTAL | $63,389,000 | $69,547,000 | $76,052,000 | $88,289,000 | $100,590,000 |
| Total Assets | $95,159,000 | $96,820,000 | $109,314,000 | $118,481,000 | $129,944,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,119,000 | 4,264,000 | 4,948,000 | 2,340,000 | 3,346,000 |
| Accounts payable and accrued liabilities | 3,259,000 | 3,040,000 | 2,949,000 | 2,713,000 | 2,445,000 |
| Other current liabilities | 15,884,000 | 14,586,000 | 13,971,000 | 14,027,000 | 12,513,000 |
| TOTAL | $22,262,000 | $21,890,000 | $21,868,000 | $19,080,000 | $18,304,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,653,000 | 35,056,000 | 39,605,000 | 48,336,000 | 43,387,000 |
| aiOther Non-Current Liabilities | 6,406,000 | 6,572,000 | 7,314,000 | 7,756,000 | 10,080,000 |
| TOTAL | $43,412,000 | $43,812,000 | $51,440,000 | $61,519,000 | $59,942,000 |
| Total Liabilities | $65,674,000 | $65,702,000 | $73,308,000 | $80,599,000 | $78,246,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,022,193 | 2,098,776 | 2,179,713 | 2,240,475 | 2,257,511 |
| Common Shares | 292,000 | 292,000 | 292,000 | 292,000 | 292,000 |
| Retained earnings | 28,766,000 | 25,503,000 | 23,820,000 | 21,281,000 | 34,474,000 |
| Other shareholders' equity | -1,491,000 | -1,224,000 | -1,208,000 | -1,779,000 | -1,420,000 |
| TOTAL | $29,485,000 | $31,118,000 | $36,006,000 | $37,882,000 | $51,698,000 |
| Total Liabilities And Equity | $95,159,000 | $96,820,000 | $109,314,000 | $118,481,000 | $129,944,000 |